New Science Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Trellis BioscienceJan 2026
BiotechRedwood City, US
Larry Kauvar(Chief Science Officer)Stefan Ryser(President and Chief Executive Officer)Geoff Dillon(Chief Business Officer)Elisabeth Whitney(Chief Operating Officer)Nora Mende(Chief Financial Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.